Navigation Links
A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier
Date:5/8/2009

"HIV/AIDS Remains the Number One Global Health Threat"

WASHINGTON, May 8 /PRNewswire-USNewswire/ -- Today, HIV co-discoverers Drs. Robert C. Gallo, director of the Institute of Human Virology at the University of Maryland School of Medicine, and Luc A. Montagnier, president of the World Foundation for AIDS Research and Prevention, called on international organizations and governments to immediately implement six objectives to end the HIV/AIDS pandemic. They made the announcement today at the National Press Club and it was followed by comments from Jeff Crowley, Director, White House Office of National AIDS Policy.

"Globally, many are acting as though HIV and AIDS are no longer the threat they were 25 years ago when the HIV virus was first discovered. However, in fact they remain an unparalleled global health threat, and despite progress in treatment, could worsen unless determined action is taken. We believe the recommendations we are making today are key to reducing and ultimately minimizing the devastation of HIV and AIDS," said Drs. Gallo and Montagnier.

Global Call to Action:

  1. Invest in medical infrastructure and educational outreach programs in U.S. communities most affected by the HIV/AIDS epidemic
  2. Promote global development of HIV/AIDS treatment and control programs along with regional research institutions in developing countries
  3. Cultivate and inspire young scientists in the field of human virology
  4. Enhance HIV/AIDS education and prevention, especially in countries with high infection rates
  5. Support cutting-edge vaccine research and the development of new effective therapies
  6. Continue the focus on preventing mother-to-child HIV transmission

"Here we are, 25 years after discovering the cause of AIDS and we still have a major, public health HIV/AIDS crisis," said Dr. Gallo. "Never in the history of mankind have we so quickly identified the cause of an epidemic, developed a test for it and begun to develop drug therapy, changing a once-deadly virus to a lifelong condition with proper medical intervention. It is important for governments and organizations from around the world to come together and combat this collective HIV/AIDS emergency."

"President Obama is fully committed to the worldwide effort to combat HIV/AIDS, and is equally committed to the effort here at home, where we are facing a serious challenge. With more than 56,000 new infections each year and more than 1.1 million people living with HIV/AIDS in the United States, we continue to have a very serious domestic epidemic. As part of the National HIV/AIDS Strategy development process, we will be developing strategies to lower HIV incidence, get all people living with HIV/AIDS into care, and address health disparities," said Jeffrey S. Crowley, Director of the White House Office of National AIDS Policy.

"Despite many advances in HIV research from the virus discovery to the antiretroviral therapy, the AIDS epidemic is still spreading and remains a major health problem in many countries," said Dr. Montagnier. "It is therefore of utmost importance to continue the research to find new ways of treatment and prevention for eradicating the virus infection."

This global action coincides with the publishing of Dr. Gallo and his colleagues' four key groundbreaking articles in Science magazine, May 4, 1984 Vol 224 (#4648). These four papers proved how the then-new, deadly virus was the cause of AIDS. This significant global contribution lead to the development of the HIV blood test, thereby diagnosing individuals and helping to control the pandemic, while paving the way for drug and vaccine research initiated at the National Cancer Institute (NCI). These reports followed the publication by Dr. Montagnier and his co-workers who showed the first existence of this new retrovirus and subsequently contributed to demonstrate its causative role in AIDS."

Drs. Gallo and Montagnier are participating in a symposium, "25 Years After Discovering HIV as the Cause of AIDS," co-hosted by the University of Maryland School of Medicine and the National Cancer Institute. The symposium, which will be held May 9-11, 2009, will look back at the origins of research on human retroviruses and the 25 years since proving HIV as the cause of AIDS, summarize the accomplishments of a successful research enterprise, and look forward to overcoming obstacles in treatment and prevention for the global AIDS epidemic. For more information, please visit http://www.gallo25.umaryland.edu/.


'/>"/>
SOURCE Institute of Human Virology of the University of Maryland School of Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... Team Type 1 Foundation, a nonprofit ... everyone affected by diabetes, is excited to announce the 106 college athletes with type ... , Established in 2005, the Team Type 1 Foundation has bestowed a total of ...
(Date:7/26/2017)... Florida (PRWEB) , ... July 26, 2017 , ... ... for dogs and cats has opened in Jupiter. The state of the ... (cardiology) and class leading treatments with a goal of providing heart patients longer ...
(Date:7/26/2017)... ... 26, 2017 , ... Isodiol International Inc. (CSE: ISOL) (OTC: ... the development of pharmaceutical and consumer products, announces the operational numbers of its ... Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues ...
(Date:7/26/2017)... ... July 26, 2017 , ... Wendy M. Musielak, a partner at the Andrew Cores ... County Bar Association’s third Vice President earlier this year. She will serve the membership in ... second Vice President, in accordance with the organization’s by-laws. , Musielak joined the ...
(Date:7/26/2017)... ... July 26, 2017 , ... The number of adults ... United States, but ways to improve asthma control in the population are not well ... Practice (JACI: In Practice), an official journal of the American Academy of Allergy, Asthma ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:7/1/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... call will be broadcast live over the Internet on Thursday, ... release detailing the quarterly results will be made available at ... The live audio webcast can be accessed via ... will be archived for replay following the conference call. ...
Breaking Medicine Technology: